These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 25576066

  • 1. Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome.
    Fujinaga S, Sakuraya K, Yamada A, Urushihara Y, Ohtomo Y, Shimizu T.
    Pediatr Nephrol; 2015 Apr; 30(4):687-91. PubMed ID: 25576066
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab.
    Fujinaga S, Someya T, Watanabe T, Ito A, Ohtomo Y, Shimizu T, Kaneko K.
    Eur J Pediatr; 2013 Apr; 172(4):513-8. PubMed ID: 23271494
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

  • 4. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
    Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
    Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
    [Abstract] [Full Text] [Related]

  • 5. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 6. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome.
    Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K.
    Pediatr Nephrol; 2007 Jan 01; 22(1):71-6. PubMed ID: 17086405
    [Abstract] [Full Text] [Related]

  • 7. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
    Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
    Clin Exp Nephrol; 2017 Aug 01; 21(4):671-676. PubMed ID: 27558467
    [Abstract] [Full Text] [Related]

  • 8. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Aug 01; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 9. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May 01; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul 01; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
    Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec 01; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 13. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children.
    Ulinski T, Dubourg L, Saïd MH, Parchoux B, Ranchin B, Cochat P.
    Pediatr Nephrol; 2005 Apr 01; 20(4):482-5. PubMed ID: 15719253
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
    Pediatr Int; 2007 Dec 01; 49(6):933-7. PubMed ID: 18045300
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome.
    Gellermann J, Weber L, Pape L, Tönshoff B, Hoyer P, Querfeld U, Gesellschaft für Pädiatrische Nephrologie (GPN).
    J Am Soc Nephrol; 2013 Oct 01; 24(10):1689-97. PubMed ID: 23813218
    [Abstract] [Full Text] [Related]

  • 16. [Mycophenolate mofetil versus cyclosporine A in children with primary refractory nephrotic syndrome].
    Geng HY, Ji LN, Chen CY, Tu J, Li HR, Bao R, Lin Y.
    Zhonghua Er Ke Za Zhi; 2018 Sep 02; 56(9):651-656. PubMed ID: 30180402
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
    Nickavar A, Safarzadeh AE, Sotoudeh K, Otukesh H, Hooman N.
    Iran J Kidney Dis; 2012 Sep 02; 6(5):346-9. PubMed ID: 22976259
    [Abstract] [Full Text] [Related]

  • 18. Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.
    Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K.
    Pediatr Nephrol; 2011 Oct 02; 26(10):1823-8. PubMed ID: 21556716
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
    Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K.
    Pediatr Nephrol; 2019 Feb 02; 34(2):353-357. PubMed ID: 30426219
    [Abstract] [Full Text] [Related]

  • 20. Randomized clinical trial to compare efficacy and safety of repeated courses of rituximab to single-course rituximab followed by maintenance mycophenolate-mofetil in children with steroid dependent nephrotic syndrome.
    Basu B, Preussler S, Sander A, Mahapatra TKS, Schaefer F.
    BMC Nephrol; 2020 Nov 30; 21(1):520. PubMed ID: 33256621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.